[1] |
夏强.突破肝移植的瓶颈阶段[J].肝胆外科杂志, 2010, 18(3): 164-166. DOI: 10.3969/j.issn.1006-4761.2010.03.002.XIA Q. Breaking through the bottleneck stage of liver transplantation[J]. J Hepatobiliary Surg, 2010, 18(3): 164- 166. DOI: 10.3969/j.issn.1006-4761.2010.03.002.
|
[2] |
MUELLER NJ, EZZELARAB M, BUHLER L, et al. Monitoring of porcine and baboon cytomegalovirus infection in xenotransplantation[J]. Xenotransplantation, 2 0 0 9, 1 6 (6) : 5 3 5 - 5 3 6. D O I : 1 0. 1111 / j. 1 3 9 9 - 3089.2009.00536.x.
|
[3] |
陶开山, 李霄, 窦科峰.异种肝移植的历史与发展[J].器官移植, 2017, 8(2): 85-88. DOI: 10.3969/j.issn.1674-7445.2017.02.001.TAO KS, LI X, DOU KF. History and development of liver xenotransplantation[J]. Organ Transplant, 2017, 8(2): 85- 88. DOI: 10.3969/j.issn.1674-7445.2017.02.001.
|
[4] |
EKSER B, EZZELARAB M, HARA H, et al. Clinical xenotransplantation: the next medical revolution?[J]. Lancet, 2012, 379(9816): 672-683. DOI: 10.1016/S0140- 6736(11)61091-X.
|
[5] |
EKSER B, COOPER DK. Overcoming the barriers to xenotransplantation: prospects for the future[J]. Expert Rev Clin Immunol, 2010, 6(2): 219-230. doi: 10.1586/eci.09.81
|
[6] |
PULLEN LC. Xenotransplantation: time to get excited?[J]. Am J Transplant, 2017, 17(12): 2995-2996. DOI: 10.1111/ajt.14553.
|
[7] |
EKSER B, LI P, COOPER DKC. Xenotransplantation: past, present, and future[J]. Curr Opin Organ Transplant, 2017, 22(6): 513-521. DOI: 10.1097/MOT.0000000000000463.
|
[8] |
SAHARA H, WATANABE H, POMPOSELLI T, et al. Lung xenotransplantation[J]. Curr Opin Organ Transplant, 2017, 22(6):541-548. DOI: 10.1097/MOT.0000000000000465.
|
[9] |
LIN CC, CHEN D, MCVEY JH, et al. Expression of tissue factor and initiation of clotting by human platelets and monocytes after incubation with porcine endothelial cells[J]. Transplantation, 2008, 86(5): 702-709. DOI: 10.1097/TP.0b013e31818410a3.
|
[10] |
NAGAYASU T, SAADI S, HOLZKNECHT RA, et al. Expression of tissue factor mRNA in cardiac xenografts:clues to the pathogenesis of acute vascular rejection[J]. Transplantation, 2000, 69(4):475-482. doi: 10.1097/00007890-200002270-00003
|
[11] |
EKSER B, LIN CC, LONG C, et al. Potential factors influencing the development of thrombocytopenia and consumptive coagulopathy after genetically modified pig liver xenotransplantation[J]. Transpl Int, 2012, 25(8):882- 896. DOI: 10.1111/j.1432-2277.2012.01506.x.
|
[12] |
LIN CC, EZZELARAB M, HARA H, et al. Atorvastatin or transgenic expression of TFPI inhibits coagulation initiated by anti-nonGal IgG binding to porcine aortic endothelial cells[J]. J Thromb Haemost, 2010, 8(9): 2001-2010. DOI: 10.1111/j.1538-7836.2010.03950.x.
|
[13] |
KIM K, SCHUETZ C, ELIAS N, et al. Up to 9-day survival and control of thrombocytopenia following alpha1, 3-galactosyl transferase knockout swine liver xenotransplantation in baboons[J]. Xenotransplantation, 2012, 19(4):256-264. DOI: 10.1111/j.1399-3089.2012. 00717.x.
|
[14] |
LIN CC, EZZELARAB M, SHAPIRO R, et al. Recipient tissue factor expression is associated with consumptive coagulopathy in pig-to-primate kidney xenotransplantation[J]. Am J Transplant, 2010, 10(7):1556- 1568. DOI: 10.1111/j.1600-6143.2010.03147.x.
|
[15] |
BROZE GJ JR, GIRARD TJ. Tissue factor pathway inhibitor: structure-function[J]. Front Biosci (Landmark Ed), 2012, 17:262-280. doi: 10.2741/3926
|